ORAL-CONTRACEPTIVE USE AND THE RISK OF TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS IN A LARGE PROSPECTIVE-STUDY OF WOMEN

被引:70
作者
RIMM, EB
MANSON, JE
STAMPFER, MJ
COLDITZ, GA
WILLETT, WC
ROSNER, B
HENNEKENS, CH
SPEIZER, FE
机构
[1] HARVARD UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BOSTON,MA 02115
[2] HARVARD UNIV,SCH PUBL HLTH,DEPT NUTR,BOSTON,MA 02115
[3] HARVARD UNIV,SCH PUBL HLTH,DEPT BIOSTAT,BOSTON,MA 02115
[4] BRIGHAM & WOMENS HOSP,BOSTON,MA 02115
关键词
ORAL CONTRACEPTIVES; DIABETES-MELLITUS; EPIDEMIOLOGY; PROSPECTIVE STUDY;
D O I
10.1007/BF00401427
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We examined the association between oral contraceptive use and incidence of Type 2 (non-insulin-dependent) diabetes mellitus among 115117 female nurses free of diabetes, cardiovascular disease and cancer in 1976 and followed-up for 12 years. During 1237 440 person years of follow-up, 2276 women who provided information on oral contraceptive use were clinically diagnosed with Type 2 diabetes. Women who used oral contraceptives in the past had only a slight and marginally increased relative risk of 1.10 (95% confidence interval 1.01, 1.21) compared to those women who had never used oral contraceptives after controlling for known risk factors of disease. We found no evidence of increased risk with longer duration of use or with shorter interval since last use. Current users did not have an increased risk of Type 2 diabetes (relative risk = 0.86, 95 % confidence interval 0.46, 1.61) when compared to women who had never used the drug. There was no effect modification by obesity, family history of diabetes, or physical activity. These data suggest that past or current oral contraceptive use does not substantially influence subsequent risk of Type 2 diabetes.
引用
收藏
页码:967 / 972
页数:6
相关论文
共 28 条
[1]   VALIDATION OF QUESTIONNAIRE INFORMATION ON RISK-FACTORS AND DISEASE OUTCOMES IN A PROSPECTIVE COHORT STUDY OF WOMEN [J].
COLDITZ, GA ;
MARTIN, P ;
STAMPFER, MJ ;
WILLETT, WC ;
SAMPSON, L ;
ROSNER, B ;
HENNEKENS, CH ;
SPEIZER, FE .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1986, 123 (05) :894-900
[2]  
COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P510
[3]   THE ABILITY OF WOMEN TO RECALL THEIR ORAL-CONTRACEPTIVE HISTORIES [J].
COULTER, A ;
VESSEY, M ;
MCPHERSON, K ;
CROSSLEY, B .
CONTRACEPTION, 1986, 33 (02) :127-137
[4]   ORAL-CONTRACEPTIVE USE - PROSPECTIVE FOLLOW-UP OF WOMEN WITH SUSPECTED GLUCOSE-INTOLERANCE [J].
DUFFY, TJ ;
RAY, R .
CONTRACEPTION, 1984, 30 (03) :197-208
[5]   ORAL-CONTRACEPTIVES, INSULIN RESISTANCE AND ISCHEMIC VASCULAR-DISEASE [J].
ESCHWEGE, E ;
FONTBONNE, A ;
SIMON, D ;
THIBULT, N ;
BALKAU, B ;
SAINTPAUL, M ;
GARNIER, P ;
SENAN, C ;
PAPOZ, L .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1990, 31 (03) :263-269
[6]   CLINICAL ASPECTS OF THE RELATIONSHIP BETWEEN ORAL-CONTRACEPTIVES, ABNORMALITIES IN CARBOHYDRATE-METABOLISM, AND THE DEVELOPMENT OF CARDIOVASCULAR-DISEASE [J].
GASPARD, UJ ;
LEFEBVRE, PJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (01) :334-343
[7]  
GESPARD UJ, 1987, AM J OBSTET GYNERCOL, V157, P1029
[8]  
GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810
[9]   THE EFFECTS OF DIFFERENT FORMULATIONS OF ORAL-CONTRACEPTIVE AGENTS ON LIPID AND CARBOHYDRATE-METABOLISM [J].
GODSLAND, IF ;
CROOK, D ;
SIMPSON, R ;
PROUDLER, T ;
FELTON, C ;
LEES, B ;
ANYAOKU, V ;
DEVENPORT, M ;
WYNN, V .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (20) :1375-1381
[10]  
GOLDMAN JA, 1978, ISRAEL J MED SCI, V14, P324